Snapshot from Aug 03, 2026 at 07:00 UTC. For live data and tracking: View Live
Domestic personal health story

Jo Fuller sells house for cancer treatment

Analysis based on 8 articles · First reported Jul 16, 2026 · Last updated Jul 17, 2026

Sentiment
-10
Attention
0
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This event is unlikely to have a direct market impact. It may increase public awareness and pressure on the UK government to fund brain cancer research, potentially affecting healthcare policy and related stocks.

Healthcare

Jo Fuller, a 51-year-old dyslexia specialist from East Leake, Nottinghamshire, was diagnosed with glioblastoma while on holiday in Australia in December 2024. After standard treatments failed, she sold her house to fund hyperthermia treatment and other therapies not available on the NHS. Brain Tumour Research urged the UK government to invest in research and expand clinical trials. The United Kingdom — Department of Health and Social Care expressed sympathy and highlighted the National Cancer Plan and NIHR trials. About 3,200 people are diagnosed with glioblastoma annually in the UK, with only 4% surviving beyond five years.

per
Jo Fuller is the patient who sold her house to fund experimental glioblastoma treatment. Her story highlights the financial burden of accessing unapproved therapies.
Importance 100.0 Sentiment -50.0
ngo
Brain Tumour Research is a charity advocating for increased government investment in brain cancer research and clinical trials. It used Fuller's case to urge policy change.
Importance 70.0 Sentiment 20.0
govactor
The NHS is the UK's public healthcare system, which does not routinely fund hyperthermia for brain tumors. The event underscores gaps in NHS coverage for experimental treatments.
Importance 60.0 Sentiment -10.0
govactor
The UK government department expressed sympathy and reiterated its commitment to improving cancer research and care through the National Cancer Plan and NIHR trials.
Importance 50.0 Sentiment 0.0
cnt
The UK is the country where Fuller resides and where the NHS operates. The event highlights challenges in the UK's healthcare system regarding access to experimental treatments.
Importance 40.0 Sentiment -5.0
govactor
NIHR is the UK's research funding body supporting brain tumor trials. It is mentioned as part of the government's response to improve outcomes.
Importance 30.0 Sentiment 10.0
cnt
Australia is where Fuller was diagnosed and initially treated. It serves as the location of her diagnosis and surgery.
Importance 20.0 Sentiment 0.0
cnt
Germany is where Fuller hopes to pursue IOZK immunotherapy if her tumor progresses, as it is not licensed in the UK.
Importance 15.0 Sentiment 0.0
United Kingdom allies Australia The United Kingdom considers Australia a vital strategic partner in the Indo-Pacific, bound by the AUKUS nuclear submari
United Kingdom allies Germany The United Kingdom considers Germany a vital strategic and economic partner in Europe, sharing defense commitments throu
Australia related Germany
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.